SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-036028
Filing Date
2013-05-01
Accepted
2013-05-01 17:00:45
Documents
12
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a13-7731_110q.htm 10-Q 944384
2 EX-10.42 a13-7731_1ex10d42.htm EX-10.42 441942
3 EX-31.1 a13-7731_1ex31d1.htm EX-31.1 12965
4 EX-31.2 a13-7731_1ex31d2.htm EX-31.2 13739
5 EX-32 a13-7731_1ex32.htm EX-32 12054
12 GRAPHIC g77311kk11i001.jpg GRAPHIC 22916
  Complete submission text file 0001104659-13-036028.txt   7855346

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT thrx-20130331.xml EX-101.INS 864201
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT thrx-20130331.xsd EX-101.SCH 84447
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT thrx-20130331_cal.xml EX-101.CAL 57335
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT thrx-20130331_lab.xml EX-101.LAB 1260802
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT thrx-20130331_pre.xml EX-101.PRE 622600
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT thrx-20130331_def.xml EX-101.DEF 412626
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 13804025
SIC: 2834 Pharmaceutical Preparations